IRD · Opus Genetics, Inc. · Documents

$4.27 +0.34 (+8.65%) At close · Nov 4

Russell 2000 member Rebalance outlook locked

Market Cap

$326.96M

83.20M

Volume · Nov 4 1.16M Avg daily vol (3M) 2.48M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2025

Apr 10

Proxy statement DEFA14A

Proxy statement

Apr 8

Registration statement S-3/A

Registration statement

Apr 7

Proxy statement DEFA14A

Proxy statement

Apr 4

Current report 8-K Events of Apr 2

Ended a material agreement

Mar 31

Current report 8-K

Financial results

Mar 31

Annual report 10-K FY2024, ended Dec 31

Annual report for FY2024

Revenue $10.99M ▼ 42.3% Net loss $57.53M Diluted EPS -$2.15

Mar 24

Current report 8-K Events of Mar 21

Unregistered sale of equity, Other events

Mar 20

Current report 8-K Events of Mar 19

Charter or bylaw amendment, or fiscal year change, Other events

Mar 20

Current report 8-K

Financial results

Mar 4

Current report 8-K

Other events

Feb 18

Registration statement S-3

Registration statement

Jan 24

Current report 8-K Events of Jan 17

Director or officer change, or executive pay

Jan 23

Current report 8-K

Other events

Jan 14

Current report 8-K Events of Jan 13

Other events

Jan 7

Current report 8-K/A Events of Oct 22

Current report

2024

Nov 12

Current report 8-K

Financial results

Nov 12

Quarterly report 10-Q FY2024 Q3, ended Sep 30

Quarterly report for FY2024 Q3

Revenue $3.87M ▼ 67.6% Net loss $7.53M Diluted EPS -$0.29

Oct 22

Current report 8-K

Entered into a material agreement, Completed an acquisition or sale of assets, Financial results, Unregistered sale of equity, Change to shareholders' rights, Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Regulation FD disclosure

Aug 13

Current report 8-K

Financial results

Aug 13

Quarterly report 10-Q FY2024 Q2, ended Jun 30

Quarterly report for FY2024 Q2

Revenue $1.11M ▼ 69.7% Net loss $7.77M Diluted EPS -$0.30

Jun 13

Current report 8-K Events of Jun 11

Charter or bylaw amendment, or fiscal year change, Shareholder vote results

May 30

Proxy statement DEFR14A

Proxy statement

May 10

Current report 8-K

Financial results

May 10

Current report 8-K

Regulation FD disclosure

May 10

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Revenue $1.71M ▼ 2.2% Net loss $7.11M Diluted EPS -$0.29

Apr 29

Proxy statement DEF 14A Meeting Jun 11, 2024

Proxy statement

Apr 29

Annual report to holders ARS

Annual report to holders

Apr 29

Proxy statement DEFA14A

Proxy statement

Apr 19

Proxy statement PRE 14A Meeting Jun 11, 2024

Proxy statement

Apr 17

Current report 8-K Events of Apr 11

Director or officer change, or executive pay

Mar 27

Current report 8-K

Regulation FD disclosure

Mar 8

Current report 8-K

Financial results

Mar 8

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Revenue $19.05M ▼ 52.2% Net loss $9.99M Diluted EPS -$0.46

Feb 16

Current report 8-K Events of Feb 12

Director or officer change, or executive pay

Jan 10

Registration statement S-3

Registration statement

2023

Dec 6

Current report 8-K Events of Dec 1

Director or officer change, or executive pay

Nov 27

Current report 8-K Events of Nov 20

Director or officer change, or executive pay, Regulation FD disclosure

Nov 13

Current report 8-K

Financial results

Nov 13

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Revenue $11.94M Net income $5.56M Diluted EPS $0.25

Nov 2

Current report 8-K

Regulation FD disclosure, Other events

Nov 1

Current report 8-K Events of Oct 30

Director or officer change, or executive pay, Regulation FD disclosure, Other events

Sep 27

Current report 8-K Events of Sep 25

Other events

Aug 11

Current report 8-K Events of Aug 10

Entered into a material agreement, Financial results

Aug 11

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Revenue $3.67M Net loss $4.96M Diluted EPS -$0.24

Aug 1

Current report 8-K

Regulation FD disclosure

Jun 14

Current report 8-K Events of Jun 8

Director or officer change, or executive pay

Jun 9

Current report 8-K Events of Jun 6

Shareholder vote results

Jun 2

Current report 8-K Events of Jun 1

Charter or bylaw amendment, or fiscal year change

May 15

Current report 8-K

Financial results, Regulation FD disclosure

May 15

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Revenue $1.75M Net loss $5.79M Diluted EPS -$0.28

Showing 51–100 of 174 documents

Key facts CIK 1228627 CUSIP 67577R102 13F (30d) 23 filings 23 filers Visit website Investor relations